Literature DB >> 12528757

Impact of smokeless tobacco use on smoking in northern Sweden.

B Rodu1, B Stegmayr, S Nasic, K Asplund.   

Abstract

BACKGROUND AND OBJECTIVES: For many years Swedish men have had the world's lowest rates of smoking and smoking-related mortality. Despite these facts, a thorough analysis of tobacco use patterns in Sweden has not been performed. The purpose of this study was to examine the prevalence and interaction of cigarette smoking and use of Swedish moist snuff (snus) in the population of northern Sweden.
DESIGN: The study cohort of 2998 men and 3092 women aged 25-64 was derived from the northern Sweden MONICA study, consisting of population-based surveys in 1986, 1990, 1994 and 1999. Detailed information on tobacco use was used to develop prevalence data, and the prevalence ratio was used to compare rates amongst various subgroups.
RESULTS: Amongst men ever-tobacco use was stable in all survey years at about 65%, but the prevalence of smoking declined from 23% in 1986 to 14% in 1999, whilst snus use increased from 22% to 30%. In women the prevalence of smoking was more stable in the first three surveys (approximately 27%) but was 22% in 1999, when snus use was 6%. In all years men showed higher prevalence of ex-smoking than women. A dominant factor was a history of snus (PR = 6.18, CI = 4.96-7.70), which was more prevalent at younger ages.
CONCLUSIONS: The recent transition from smoking to snus use amongst men, and incipiently amongst women, in northern Sweden is remarkable and relevant to the global discussion on strategies to reduce smoking.

Entities:  

Mesh:

Year:  2002        PMID: 12528757     DOI: 10.1046/j.1365-2796.2002.01057.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  33 in total

1.  Role of snus in initiation and cessation of tobacco smoking in Sweden.

Authors:  L M Ramström; J Foulds
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

2.  Should doctors advocate snus and other nicotine replacements? Yes.

Authors:  John Britton
Journal:  BMJ       Date:  2008-02-16

3.  Sweden SimSmoke: the effect of tobacco control policies on smoking and snus prevalence and attributable deaths.

Authors:  Aimee M Near; Kenneth Blackman; Laura M Currie; David T Levy
Journal:  Eur J Public Health       Date:  2013-11-27       Impact factor: 3.367

Review 4.  Impact of differing definitions of dual tobacco use: implications for studying dual use and a call for operational definitions.

Authors:  Robert C Klesges; Jon O Ebbert; Glen D Morgan; Deborah Sherrill-Mittleman; Taghrid Asfar; Wayne G Talcott; Margaret Debon
Journal:  Nicotine Tob Res       Date:  2011-03-24       Impact factor: 4.244

5.  The burden of mortality from smoking: comparing Sweden with other countries in the European Union.

Authors:  Brad Rodu; Philip Cole
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Authors:  Helena Furberg; Paul Lichtenstein; Nancy L Pedersen; Laura Thornton; Cynthia M Bulik; Caryn Lerman; Patrick F Sullivan
Journal:  Nicotine Tob Res       Date:  2008-12       Impact factor: 4.244

Review 7.  Effect of smokeless tobacco (snus) on smoking and public health in Sweden.

Authors:  J Foulds; L Ramstrom; M Burke; K Fagerström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

8.  European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.

Authors:  C Bates; K Fagerström; M J Jarvis; M Kunze; A McNeill; L Ramström
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

Review 9.  Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction.

Authors:  David S Timberlake; Jason A Zell
Journal:  BMC Med       Date:  2009-10-19       Impact factor: 8.775

10.  Patterns and behaviors of snus consumption in Sweden.

Authors:  Helena Digard; Graham Errington; Audrey Richter; Kevin McAdam
Journal:  Nicotine Tob Res       Date:  2009-08-17       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.